Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ONCOS-102
i
Other names:
ONCOS-102, Ad5/3-D24-GMCSF, CGTG-102, ONCOS 102, ONCOS102, Ad5/3-D24-GM-CSF
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Circio Holding
Drug class:
GM-CSF agonist
Related drugs:
‹
talimogene laherparepvec (9)
CG0070 (1)
BS001 (0)
allogeneic GM-CSF-secreting tumor cells (0)
GVAX leukemia vaccine (0)
GVAX lung cancer vaccine (0)
sargramostim (0)
filgrastim (0)
OrienX010 (0)
pexastimogene devacirepvec (0)
PSA/IL-2/GM-CSF vaccine (0)
gemogenovatucel-T (0)
allogeneic Myeloma GM-CSF Vaccine (0)
talimogene laherparepvec (9)
CG0070 (1)
BS001 (0)
allogeneic GM-CSF-secreting tumor cells (0)
GVAX leukemia vaccine (0)
GVAX lung cancer vaccine (0)
sargramostim (0)
filgrastim (0)
OrienX010 (0)
pexastimogene devacirepvec (0)
PSA/IL-2/GM-CSF vaccine (0)
gemogenovatucel-T (0)
allogeneic Myeloma GM-CSF Vaccine (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Melanoma
No biomarker
Melanoma
ONCOS-102
Sensitive: B - Late Trials
ONCOS-102
Sensitive
:
B
ONCOS-102
Sensitive: B - Late Trials
ONCOS-102
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login